Centene's (CNC) Outperform Rating Reiterated at Oppenheimer

Oppenheimer reaffirmed their outperform rating on shares of Centene (NYSE:CNC – Free Report) in a research note published on Monday morning, Benzinga reports. Oppenheimer currently has a $110.00 price target on the stock. Other analysts have also issued reports about the company. Barclays began coverage on Centene in a report on Wednesday, March 6th. They […]

Related Keywords

United States , Kennethj Fasola , Lori Jean Robinson , Centene Corporation , Barclays , Blue Trust Inc , Cantor Fitzgerald , Sandy Spring Bank , Hohimer Wealth Management , Wells Fargo Company , Securities Exchange Commission , First Bank , Free Report , Moderate Buy , Stock Down , Get Free Report , President Kenneth , Director Lori Jean Robinson , Exchange Commission , Wealth Management , Spring Bank , Blue Trust , Centene Daily , Centene , Nyse Cnc , Cnc , Medical , 15135b10 , Reiterated Rating , Oppenheimer Holdings Inc ,